Grant: Cat Gr: Develop./validation of new biomedical techniques/technolo.- General Pool
University of Toronto
$249,250.00
Establishing a rapid selection method for selection of high affinity aptamer sensors containing non-natural nucleic acids
FY 2024-25
Summary
Small molecules are at the heart of biology and healthcare. Glucose, vitamins, amino acids - the levels of these small molecules tell us about our health and mistakes in regulating their levels cause disease. Small molecules are also how we treat most diseases in the form of drugs and natural products. Although small molecules are critical in so much of biology, they present a huge challenge - they are very difficult to measure. The reason is that each small molecule is very different: glucose looks nothing like aspirin, vitamin D looks nothing like tylenol. That means that unlike DNA sequencing, where one technology can read any sequence, there is no single technology that can easily 'read' any small molecule. We aim to change that.
We invented a new technology which does a trick: instead of trying to read each small molecule directly, we make each small molecule release a different piece of DNA: glucose releases one sequence, vitamin D releases another sequence. This means that we can measure many different small molecules at once using the huge power of DNA sequencing.
This technology relies on small sensors called 'aptamers' to match each molecule with a unique DNA sequence. We have developed very fast ways to make these sensors and these sensors are pretty good but not always as sensitive as we would like. It's a little like a camera that is great if there's lots of light but isn't sensitive enough to take good pictures at dusk. How do we fix this?
What we want to do here is expand our fast ways to make sensors to find new ones made out of units that don't exist in nature. These can give better shapes and let us 'see' small molecules even when they are at low levels. This will let us build collections of sensors to many small molecules ranging from metabolites to drugs - these will be at the core of this beautiful new technology that lets us see small molecules using DNA sequencing.
Department
Program
Cat Gr: Develop./validation of new biomedical techniques/technolo.- General Pool
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
513110
Name
Fraser Andrew G
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Catalyst Grant: Development and validation of new biomedical techniques and technologies
Projecttitle
Establishing a rapid selection method for selection of high affinity aptamer sensors containing non-natural nucleic acids
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$249,250
Cihrequipment2
$40,000
Programname2
Cat Gr: Develop./validation of new biomedical techniques/technolo.- General Pool
Keyworddelim
Aptamer; Biosensor; Dna Barcode; Metabolite Detection; Non-Natural Nucleic Acids
Abstract
Small molecules are at the heart of biology and healthcare. Glucose, vitamins, amino acids - the levels of these small molecules tell us about our health and mistakes in regulating their levels cause disease. Small molecules are also how we treat most diseases in the form of drugs and natural products. Although small molecules are critical in so much of biology, they present a huge challenge - they are very difficult to measure. The reason is that each small molecule is very different: glucose looks nothing like aspirin, vitamin D looks nothing like tylenol. That means that unlike DNA sequencing, where one technology can read any sequence, there is no single technology that can easily 'read' any small molecule. We aim to change that.
We invented a new technology which does a trick: instead of trying to read each small molecule directly, we make each small molecule release a different piece of DNA: glucose releases one sequence, vitamin D releases another sequence. This means that we can measure many different small molecules at once using the huge power of DNA sequencing.
This technology relies on small sensors called 'aptamers' to match each molecule with a unique DNA sequence. We have developed very fast ways to make these sensors and these sensors are pretty good but not always as sensitive as we would like. It's a little like a camera that is great if there's lots of light but isn't sensitive enough to take good pictures at dusk. How do we fix this?
What we want to do here is expand our fast ways to make sensors to find new ones made out of units that don't exist in nature. These can give better shapes and let us 'see' small molecules even when they are at low levels. This will let us build collections of sensors to many small molecules ranging from metabolites to drugs - these will be at the core of this beautiful new technology that lets us see small molecules using DNA sequencing.
Competitiondate
202407
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Fraser, Andrew G
Approvedterm
2 ans 0 mois
Cihrcontribution2
ICR~ $10,000~ $40,000~IG~ $239,250~ $0~